This case report describes the successful management of a patient with diabetic ketoacidosis, who developed torsades de pointes leading to nine cardiac arrests secondary to intravenous fluconazole administration on a background of hypokalaemia and hypocalcaemia.
Arrhythmias in the intensive care unit (ICU) are extremely common and those with a high potential to quickly destabilise to ventricular fibrillation (VF) are dangerous. Electrolyte imbalances, particularly involving potassium and calcium, are one of the most common causes of such arrhythmias. We report a female patient who suffered from nine episodes of possible fluconazole-induced ventricular fibrillation on a background of hypokalaemia and hypocalcaemia. She made a complete recovery and was subsequently discharged from the ICU.
CASE HISTORY
A 26-year-old, two months postpartum female patient suffering from diabetic ketoacidosis was transferred to the ICU with sepsis, persistent acidosis, hyperglycaemia, non-oliguric renal failure, nosocomial pneumonia and acute lung injury. Her vital signs on admission to the ICU were as follows: blood pressure 110/60 mmHg on 10 µg/kg/min of dopamine infusion (started in the hospital ward), pulse 120 /min and regular, temperature 38.3°C, acidotic breathing at 22 breaths/min. She was shiftedto the ICU with an endotracheal tube in situ. Her Glasgow Coma Score was E1M1Vt, her APACHE II score was 44 and SOFA score was 4. Her bloodinvestigations are shown in Table 1 . Her initial treatment consisted of full support ventilation (synchronised intermittent mandatory ventilation plus pressure support mode), correction of acidosis by ensuring adequate ventilation, sedation with morphine and midazolam infusions, antibiotics (imipenem, ciprofloxacin and metronidazole), insulin infusion, low molecular weight heparin, institution of invasive arterial and central venous pressure monitoring and enteral nutrition. In addition, on day four she was found to have hypocalcaemia (1.64 mmol/l) [2.2 to 2.6 mmol/l] and hypophosphataemia (0.70 mmol/l) [0.81 to 1.4 mmol/l].
Her urine culture showed candiduria. A bronchoalveolar lavage culture grew Acinetobacter baumanni sensitive to imipenem along with Candida species. She was started on oral fluconazole tablets 200 mg daily, calcium by intravenous infusion and was transfused two units of packed red cells. Her ventilatory parameters and renal function improved over the next few days. However, on the ninth day, she needed to be commenced on parenteral nutrition due to a paralytic ileus and subsequently her oral fluconazole was changed to an intravenous formulation. After about 22 hours she started having polymorphic ventricular ectopics in her electrocardiogram (ECG) tracing with a prolonged QTc interval (0.56 seconds) and prominent U wave. After another two hours, she had one episode of polymorphic ventricular tachycardia (VT) (torsades des pointes) which quickly worsened to VF. She was defibrillated with 200 J (biphasic) shock followed by standard advanced cardiac life support protocol. Her post cardiac arrest electrolytes are shown in Table 1 . The ECG continued to show runs of VT, pulseless electrical activity and bigeminy.
In view of low serum calcium, potassium and magnesium, replacement of all three was started as per standard protocols. As amiodarone was contraindicated in the face of prolonged QT interval, a lignocaine 100 mg bolus was also given and was followed by an infusion (60 mg/hour) to control the arrhythmia. However, episodes of polymorphic VT (torsades)/bigeminy/pulseless electrical activity continued with a total of nine episodes of VF (seven requiring defibrillation and CPR whereas the other two spontaneously reverted to sinus rhythm) over the next 24 hours. The longest CPR lasted for around 30 minutes. She was haemodynamically stable in between the episodes of VF and did not require inotropic support. After 24 hours the lignocaine infusion was tapered off. Her investigations at this time were within normal limits. She was fully conscious and well oriented, with a Glasgow Coma Score of E4M6Vt. A provisional diagnosis of hypokalaemia and hypocalcaemiainduced ventricular arrhythmia was made. The polymorphic ventricular ectopics again appeared the next day associated with slow heart rate (60 beats/min), QTc of 0.52 seconds and runs of VT. Lignocaine was restarted. The electrolytes at this time were almost normal (calcium 2.2 mmol/l with albumin 27 g/l, potassium 3.4 mmol/l, sodium 136 mmol/l). After about 20 minutes her rhythm became normal. Over the next few hours she remained stable on a lignocaine infusion; her ileus improved and after acceptance of a standard test feed, total parenteral nutrition was stopped and enteral feeds through the nasogastric route were started. Intravenous fluconazole was stopped and replaced by amphotericin B (30 mg/day) on a suspicion of drug-induced QT prolongation.
The arrhythmias stopped over the next 24 hours and lignocaine was tapered off. She was weaned off the ventilator and extubated on the 15th day. Her QTc interval in the ECG dropped to 0.4 seconds and all electrolyte imbalances were corrected. An echocardiogram was performed which was normal. She was discharged to the endo-crinology ward and subsequently discharged with no neurocognitive deficit.
DISCUSSION
The cause of the prolonged QT syndrome and torsades des pointes in our patient could have been due to congenital long QT syndrome, abnormalities in serum electrolytes, possible peripartum cardiomyopathy or as a side-effect of certain medications. Our patient did not have a prolonged QTc interval in her previous ECG on admission, and the fact that QTc reverted back to normal makes a congenital long QT syndrome less likely. The echocardiogram done before discharge from the ICU showed normal ejection fraction and no wall motion abnormality. The fact that the polymorphic VT continued even after normalisation of electrolyte levels (calcium 2.3 mmol/l and potassium 3.6 mmol/l) but stopped after discontinuing fluconazole for 24 hours, supports the assumption of fluconazole-induced torsades.
A literature review revealed fluconazole-induced torsades des pointes in a number of cases [1] [2] [3] [4] 10 . The diagnosis in these case reports has been made by exclusion and probability scoring, as drug levels of fluconazole could not be done. This was true for our patient also. Torsades is often drug-related 6 , however there are other risk factors. These include female gender 7 , hypokalaemia, hypomagnesaemia, hypocalcaemia, diuretic consumption, bradycardia, drugs known to prolong the QT interval, concomitant delayed rectifier potassium channel (I Kr ) blockers, recent conversion from atrial fibrillation, heart failure or hypertrophy, and a history of acquired or congenital QT prolongation syndromes. Common drugs causing QT prolongation are anti-arrhythmics, antihistamines, calcium channel blockers, psychotherapeutics and antibiotics including the antifungals.
Our patient, being female, was naturally more prone to arrhythmias secondary to QT prolongation and the presence of hypokalaemia, hypocalcaemia and low normal magnesium levels could have been contributing factors. It is interesting to note that amiodarone 5 , mentioned in advanced cardiac life support protocol as an option in resistant VF, itself causes QT prolongation and creates a vicious cycle. We therefore treated our patient with intravenous magnesium followed by lignocaine infusion in addition to correction of the other compounding factors.
Fluconazole 4 is a triazole antifungal agent with activity against several Candida species. Most fluconazole elimination takes place in the urine, although approximately 11% of the dose appears to be metabolised in the liver. In our patient, altered drug binding from hypoproteinaemia and renal compromise might have resulted in a high serum concentration of intravenous fluconazole.
Azole antifungals, like fluconazole, precipitate torsades by inhibiting the rapidly activating component of the I Kr 2 . The propensity of certain patients to have an exaggerated response to I Kr -blocking agents (an estimated 1.6% of the population from a gene polymorphism 2 ) may be clinically silent (without baseline QT-interval prolongation) until an agent is added. It is common practice to start an antifungal like fluconazole empirically in critically ill diabetic patients with chest infection or ventilator-associated pneumonia not responding to antibiotics. In patients who need antifungal treatment for systemic candidiasis but have a prolonged QT interval, caspofungin may be preferable to amphotericin B as far as arrhythmogenic potential is concerned 11 and should be considered as the drug of choice.
In conclusion, this case report highlights the propensity of fluconazole to prolong QT interval leading to potentially fatal arrhythmias in certain critically ill patients. This warrants careful usage of this drug in the ICU, with vigilant monitoring.
